Alternatively, metformin may exhibit direct inhibitory effects on cancer cells that are achieved by liver kinase B1 (LKB1)-mediated activation of AMP-activated protein kinase (AMPK), a negative regulator of PI3K/Akt/mTOR signaling and protein synthesis4. The gene discussed is STK11; the disease is cancer.